Shopping Cart
Remove All
Your shopping cart is currently empty
Synonyms:


| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | $148 | - | In Stock | |
| 5 mg | $378 | - | In Stock | |
| 10 mg | $619 | - | In Stock | |
| 25 mg | $1,230 | - | In Stock | |
| 1 mL x 10 mM (in DMSO) | $523 | - | In Stock |
| Description | MYC degrader 1 is an orally bioavailable MYC protein degrader with antitumor activity. It can restore the function of pRB1 protein and re-sensitize MYC-overexpressing tumor cells to CDK4/6 inhibitors. |
| In vitro | Methods: A variety of tumor cell lines were treated with MYC degrader 1 alone or in combination with Palbociclib. The degradation level of MYC protein, cell proliferation IC₅₀, cell cycle-related genes and colony formation ability were detected. Results: : 1.MYC degrader 1 (0–1000 nM, 24 h) could degrade MYC protein in T24, C4-2, MDA-MB-231, 22RV1, T47D and UMUC14 cells. 2.MYC degrader 1 (10 nM, 24 h) pretreatment could significantly increase the sensitivity of T24 and UMUC14 cells to Palbociclib, and the IC₅₀ of the two decreased from 8.37 μM and 97.39 μM to 3.11 μM and 10.23 μM respectively. 3.MYC degrader 1 (10 nM, 24 h) could synergistically enhance the inhibitory effect of Palbociclib on cell cycle-related genes in drug-resistant tumor cell lines T24, C4-2 and MDA-MB-231, and reduce the ability of cell colony formation [1]. |
| In vivo | Methods: Tumor-bearing mice were orally administrated with MYC degrader 1 alone or in combination with Palbociclib by gavage, and its effects on the growth of T24, UMUC14 and MYC-deficient xenograft tumors were observed. Results: : 1.MYC degrader 1 (6 mg/kg, oral administration, once a day for 7 consecutive days) could significantly inhibit the growth of T24 and UMUC14 xenograft tumors in mice, while exerting no obvious effect on MYC-deficient xenograft tumors. 2.MYC degrader 1 (6 mg/kg, gavage, once a day for 30 consecutive days) could markedly enhance the inhibitory effect of Palbociclib on tumor growth in T24 xenograft mice [1]. |
| Molecular Weight | 626.07 |
| Formula | C32H31ClF3N5O3 |
| Cas No. | 2946670-96-6 |
| Smiles | O=C1NC(=O)C(N2C(=O)C3=CC=C(C=C3C2)CNCC4CCN(C=5N=CC(=CC5C(F)(F)F)C6=CC=CC(Cl)=C6)CC4)CC1 |
| Storage | Keep away from moistureKeep away from direct sunlight Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (127.78 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density. | ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.